Notice of AGM & Annual Report & Accounts

1st June 2022 - 8:30 am

ImmuPharma PLC (LSE AIM: IMM), the specialist drug discovery and development company, confirms that the Notice of Annual General Meeting (“AGM”) has been posted to shareholders. The Annual Report and Accounts for the year ended 31 December 2021 will be posted to shareholders on 6 June 2022.

These documents will be available shortly, in electronic form, for download on the Company’s website

ImmuPharma’s AGM will be held on Tuesday 28 June 2022 @ 10.30am (BST) at: One Bartholomew Close, London, EC1A 7BL.


To download this announcement click here

Share this article